Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2026-01-02 @ 7:40 AM
Study NCT ID:
NCT02371967
Status:
COMPLETED
Last Update Posted:
2020-10-09
First Post:
2015-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Advanced Basal Cell Carcinoma (BCC)
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-19
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-20
First Submit QC Date:
None
Study First Post Date:
2015-02-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-08
Last Update Post Date:
2020-10-09
Last Update Post Date Type:
ACTUAL